Favipiravir in Hospitalized COVID-19 Patients

NCT04359615 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Favipiravir
DRUG: Hydroxychloroquine

Sponsor

Shahid Beheshti University of Medical Sciences